Your browser doesn't support javascript.
loading
Low-grade serous ovarian cancer: expert consensus report on the state of the science.
Grisham, Rachel N; Slomovitz, Brian M; Andrews, Nicole; Banerjee, Susana; Brown, Jubilee; Carey, Mark S; Chui, Herman; Coleman, Robert L; Fader, Amanda N; Gaillard, Stephanie; Gourley, Charlie; Sood, Anil K; Monk, Bradley J; Moore, Kathleen N; Ray-Coquard, Isabelle; Shih, Ie-Ming; Westin, Shannon N; Wong, Kwong-Kwok; Gershenson, David M.
Afiliación
  • Grisham RN; Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York, USA grishamr@mskcc.org.
  • Slomovitz BM; Department of Gynecologic Oncology, Mount Sinai Medical Center, Miami Beach, Florida, USA.
  • Andrews N; Florida International University, Miami, Florida, USA.
  • Banerjee S; STAAR Ovarian Cancer Foundation, Western Springs, Illinois, USA.
  • Brown J; The Royal Marsden and the ICR, London, UK.
  • Carey MS; Department of Gynecologic Oncology, Levine Cancer Institute at Atrium Health, Wake Forest University, Charlotte, North Carolina, USA.
  • Chui H; Division of Gynecologic Oncology, Vancouver Coastal Health, Vancouver, British Columbia, Canada.
  • Coleman RL; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Fader AN; Sarah Cannon Research Institute (SCRI), Nashville, Tennessee, USA.
  • Gaillard S; Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
  • Gourley C; Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
  • Sood AK; Cancer Research UK Scotland Centre, University of Edinburgh, Edinburgh, UK.
  • Monk BJ; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Moore KN; Division of Gynecologic Oncology, Honor Health, University of Arizona, Creighton University, Phoenix, Arizona, USA.
  • Ray-Coquard I; Department of Gynecologic Oncology, Stephenson Cancer Center at the University of Oklahoma Health Sciences, Oklahoma City, Oklahoma, USA.
  • Shih IM; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
  • Westin SN; Université Claude Bernard Lyon 1, Villeurbanne, France.
  • Wong KK; Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
  • Gershenson DM; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Int J Gynecol Cancer ; 33(9): 1331-1344, 2023 09 04.
Article en En | MEDLINE | ID: mdl-37591609
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Ováricas / Neoplasias Peritoneales / Cistadenocarcinoma Seroso / Cistadenocarcinoma Papilar Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies Límite: Female / Humans Idioma: En Revista: Int J Gynecol Cancer Asunto de la revista: GINECOLOGIA / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Ováricas / Neoplasias Peritoneales / Cistadenocarcinoma Seroso / Cistadenocarcinoma Papilar Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies Límite: Female / Humans Idioma: En Revista: Int J Gynecol Cancer Asunto de la revista: GINECOLOGIA / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos